DESCRIPTION This small molecule acts as an inhibitor of the activity of mixed lineage kinase domain like pseudokinase MLKL. The compound binds the nucleotide binding site within the MLKL pseudokinase domain and reduces MLKL translocation to the cell membrane, which has the effect of preventing MLKL-driven necroptosis (necroptosis being a form of regulated inflammatory cell death ) . This effect is driven by blocking the conformational change in the N-terminal four-helix bundle (4HB) domain of the protein caused by nucleotide binding that is required for membrane translocation and killing activity. This compound was originally identified as a nanomolar potency inhibitor of VEGFR2 tyrosine kinase , but note that inhibition of VEGFR2 by another VEGFR2 inhibitor () does not prevent necroptosis, suggesting a direct role for MLKL in this form of cell death, and also demonstrates that targeting the nucleotide binding site of pseudokinases is a novel strategy for modulating signal transduction. In summary, MLKL compound 1 provides a useful tool for investigating necroptosis. (GtoPdb)

DESCRIPTION GW806742X, an ATP mimetic and a potent MLKL (Mixed Lineage Kinase Domain-Like protein) inhibitor, binds the MLKL pseudokinase domain with a Kd of 9.3 ¦ÌM. GW806742X has activity against VEGFR2 (IC50=2 nM). GW806742X retards MLKL membrane translocation and inhibits necroptosis[1][2].

PRICE 69

DESCRIPTION GW806742X is an inhibitor of Mixed Lineage Kinase Domain-Like protein (MLKL) which binds the MLKL pseudokinase domain (Kd: 9.3 ??M) with anti-necroptosis activity. GW806742X has activity against VEGFR2.

DESCRIPTION GW806742X hydrochloride, an ATP mimetic and a potent MLKL (Mixed Lineage Kinase Domain-Like protein) inhibitor, binds the MLKL pseudokinase domain with a Kd of 9.3 ¦ÌM. GW806742X hydrochloride has activity against VEGFR2 (IC50=2 nM). GW806742X hydrochloride retards MLKL membrane translocation and inhibits necroptosis[1][2].

DESCRIPTION GW806742X is an inhibitor of Mixed Lineage Kinase Domain-Like protein (MLKL) which binds the MLKL pseudokinase domain (Kd: 9.3 μM) with anti-necroptosis activity. GW806742X has activity against VEGFR2. (TargetMol Bioactive Compound Library)